DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Vinorelbine
Vinorelbine
Eliminating Vincristine Administration Events
Paclitaxel, Vinorelbine and 5-Fluorouracil in Breast Cancer Patients Pretreated with Adjuvant Anthracyclines
Natural Products. a History of Success and Continuing Promise for Drug Discovery and Development
Vinorelbine Inj. USP
DRUG NAME: Vinorelbine
Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies
CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS
Thames Valley Chemotherapy Regimens Lung Cancer
The Cost Burden of Blood Cancer Care a Longitudinal Analysis of Commercially Insured Patients Diagnosed with Blood Cancer
Vinorelbine and Docetaxel Combination As the First Line Treatment in Patients with Metastatic Breast Cancer: Results of a Multi
Regulatory Information 12152014
NAVELBINE® (Vinorelbine) Injection, for Intravenous Use Recommended Management Procedures (5.4) Initial U.S
Cancer Drug Costs for a Month of Treatment at Initial Food
NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010
2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
Vinorelbine Is a Semi-Synthetic Vinca-Alkaloid with a Broad Spec- Molecular Mechanisms of Action Trum of Anti-Tumour Activity
Combination Chemotherapy with Docetaxel, Vinorelbine and Estramustine Phosphate in Metastatic Androgen-Resistant Prostate Cancer: a Single Institution Experience
Hoosier Oncology Group Randomized Phase II Study of Docetaxel
Top View
Dose Escalation of Oral Vinorelbine in Combination with Estramustine in Hormone-Refractory Adenocarcinoma of the Prostate
(MVD) in the Treatment of Metastatic Hormonoresistant Prostate Cancer — a Phase II Trial
Package Leaflet: Information for the User
Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
Emetogenic Potential of Antineoplastic Agents
LUNG CANCER TREATMENT REGIMENS (Part 1 of 7) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
Handling Cytostatic Drugs: Contents
Sequential Docetaxel Followed by Epirubicin-Vinorelbine As First-Line Chemotherapy in Advanced Breast Cancer
TAXOTERE: TAXOTERE Safely and Effectively
Low Dose of Arsenic Trioxide Inhibits Multidrug Resistant-Related P-Glycoprotein Expression in Human Neuroblastoma Cell Line
Vinorelbine and Continuous Low-Dose Cyclophosphamide As Maintenance
An Inventory of Medicinal Products Causing Skin Rash: Clinical and Regulatory Lessons
Vinorelbine and 5-Fluorouracil Bolus And/Or Continuous Venous Infusion Plus Levofolinic Acid As Second-Line Chemotherapy For
Efficacy and Toxicity of Different Chemotherapy Protocols For
First-Line Chemotherapy with Fluorouracil-Epirubicin-Navelbine (FEN) Combination in Advanced Breast Cancer
Guidelines for the Use of Anti-Emetics with Chemotherapy
Shortages and Price Variability of Essential Cytotoxic Medicines for Treating Children with Cancers
Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products